Literature DB >> 1703691

Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.

S Takaya1, R Duquesnoy, Y Iwaki, J Demetris, A Yagihashi, O Bronsther, S Iwatsuki, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1703691      PMCID： PMC2975536     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  14 in total

1.  Hyperacute rejection in liver transplantation: a case report.

Authors:  G Bird; P Friend; P Donaldson; J O'Grady; B Portmann; R Calne; R Williams
Journal:  Transplant Proc       Date:  1989-08       Impact factor: 1.066

Review 2.  Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction.

Authors:  T E Starzl; M Ishikawa; C W Putnam; K A Porter; R Picache; B S Husberg; C G Halgrimson; G Schroter
Journal:  Transplant Proc       Date:  1974-12       Impact factor: 1.066

Review 3.  Evolution of liver transplantation.

Authors:  T E Starzl; S Iwatsuki; D H Van Thiel; J C Gartner; B J Zitelli; J J Malatack; R R Schade; B W Shaw; T R Hakala; J T Rosenthal; K A Porter
Journal:  Hepatology       Date:  1982 Sep-Oct       Impact factor: 17.425

4.  Liver transplantation against T cell-positive warm crossmatches.

Authors:  S Iwatsuki; B S Rabin; B W Shaw; T E Starzl
Journal:  Transplant Proc       Date:  1984-12       Impact factor: 1.066

5.  Successful liver transplantation from crossmatch-positive donors.

Authors:  S Iwatsuki; Y Iwaki; T Kano; G Klintmalm; L J Koep; R Weil; T E Starzl
Journal:  Transplant Proc       Date:  1981-03       Impact factor: 1.066

6.  Evaluation of dithiothreitol (DTT) for inactivation of IgM antibodies.

Authors:  T Okuno; N Kondelis
Journal:  J Clin Pathol       Date:  1978-12       Impact factor: 3.411

7.  Evidence for hyperacute rejection of human liver grafts: The case of the canary kidneys.

Authors:  Thomas E Starzl; Anthony J Demetris; Satoru Todo; Yoogoo Kang; Andreas Tzakis; Rene Duquesnoy; Leonard Makowka; Barbara Banner; Waldo Concepcion; Kendrick A Porter
Journal:  Clin Transplant       Date:  1989       Impact factor: 2.863

8.  Immunoglobulin class and specificity of antibodies causing positive T cell crossmatches. Relationship to renal transplant outcome.

Authors:  J R Chapman; C J Taylor; A Ting; P J Morris
Journal:  Transplantation       Date:  1986-12       Impact factor: 4.939

9.  Hepatic transplantation into sensitized recipients. Demonstration of hyperacute rejection.

Authors:  S J Knechtle; P C Kolbeck; S Tsuchimoto; A Coundouriotis; F Sanfilippo; R R Bollinger
Journal:  Transplantation       Date:  1987-01       Impact factor: 4.939

10.  Extended preservation of human liver grafts with UW solution.

Authors:  S Todo; J Nery; K Yanaga; L Podesta; R D Gordon; T E Starzl
Journal:  JAMA       Date:  1989-02-03       Impact factor: 56.272
View more
  19 in total

1.  Increased bile duct complications and/or chronic rejection in crossmatch positive human liver allografts.

Authors:  S Takaya; A Jain; A Yagihashi; K Nakamura; M Kobayashi; K Takeuchi; S Suzuki; Y Iwaki; A J Demetris; S Todo; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1999-08       Impact factor: 1.066

2.  Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts.

Authors:  T Furuya; N Murase; K Nakamura; J Woo; S Todo; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

3.  Retransplantation of liver: a comparison of FK 506- and cyclosporine-treated patients.

Authors:  S Takaya; O Bronsther; S Todo; K Abu-Elmagd; A Jain; M Alessiani; J Madariaga; I R Marino; R Selby; J J Fung
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Correlation of rejection episodes with FK 506 dosage, FK 506 level, and steroids following primary orthotopic liver transplant.

Authors:  A B Jain; S Todo; J J Fung; R Venkataramanan; R Day; J Bryant; K M Abu-Elmagd; M Alessiani; S Takaya; A Tzakis
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

5.  The lymphocytotoxic crossmatch in liver transplantation: a clinicopathologic analysis.

Authors:  K Nakamura; A Yagihashi; Y Iwaki; S Takaya; G G Hartman; N Murase; O Bronsther; R Manez; J J Fung; S Iwatsuki
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

6.  Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

Authors:  S Takaya; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

7.  High mean fluorescence intensity donor-specific anti-HLA antibodies associated with chronic rejection Postliver transplant.

Authors:  J G O'Leary; H Kaneku; B M Susskind; L W Jennings; M A Neri; G L Davis; G B Klintmalm; P I Terasaki
Journal:  Am J Transplant       Date:  2011-06-14       Impact factor: 8.086

8.  Class II alloantibody and mortality in simultaneous liver-kidney transplantation.

Authors:  J G O'Leary; H M Gebel; R Ruiz; R A Bray; J D Marr; X J Zhou; S M Shiller; B M Susskind; A D Kirk; G B Klintmalm
Journal:  Am J Transplant       Date:  2013-02-22       Impact factor: 8.086

9.  The role of donor-specific HLA alloantibodies in liver transplantation.

Authors:  J G O'Leary; A J Demetris; L S Friedman; H M Gebel; P F Halloran; A D Kirk; S J Knechtle; S V McDiarmid; A Shaked; P I Terasaki; K J Tinckam; S J Tomlanovich; K J Wood; E S Woodle; A A Zachary; G B Klintmalm
Journal:  Am J Transplant       Date:  2014-03-01       Impact factor: 8.086

10.  Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.

Authors:  S L Saidman; R J Duquesnoy; A J Demetris; J McCauley; H Ramos; G Mazariegos; R Shapiro; T E Starzl; J J Fung
Journal:  Transpl Immunol       Date:  1994       Impact factor: 1.708
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.